Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent.

Authors
Publication date
12 December 2019
Publisher
Providence St. Joseph Health Digital Commons

Abstract

Purinergic receptor is a potential drug target for neuropathic pain, Alzheimer disease, and prostate cancer. Focusing on the structure-based ligand discovery, docking analysis on the crystal structure of P2

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Providence St. Joseph Health Digital Commons

    redirect
    oaioai:digitalcommons.providence....
    Last time updated on 17/10/2023